Search

everythinglearnresearchcommunity

for

Search:↓

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

High DHA levels delay wound healing and worsen skin repair quality.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

IL-36α helps grow new hair follicles and speeds up wound healing.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Clausena anisata may be effective in treating acne due to its ability to fight bacteria, reduce inflammation, and possibly lower sebum production.

The document discusses various skin disorders and new therapeutic approaches.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

The substance from human hair root cells can help maintain hair growth and make skin cells more capable of growing hair.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Pine bark extract helps mice grow hair by reducing inflammation and boosting growth factors.

HYDRO DELUXE BIO hyaluronic acid hydrogel is compatible with skin cells, may reduce inflammation, promote blood vessel growth, and protect against oxidative stress, suggesting it could help revitalize hair follicles.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Garden cress extract may help treat skin inflammation and androgen-related disorders.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Magnesium oxide-infused membranes help heal wounds faster by reducing inflammation and promoting skin and hair follicle growth.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

The herbal preparation may help manage alopecia by reducing inflammation and boosting the immune response.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Implanting hair-follicle stem cells in mice brains helped repair brain bleeding and reduced brain inflammation.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

ILC1 cells contribute to hair loss in alopecia areata.

Serenoa repens and N-acetyl glucosamine/milk proteins complex may help with hair growth and prevent hair loss.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.